Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below 200 Day Moving Average – Here’s Why

Kewaunee Scientific Corporation (NASDAQ:KEQU)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $45.50 and traded as low as $38.85. Kewaunee Scientific shares last traded at $39.33, with a volume of 7,487 shares.

Analysts Set New Price Targets

KEQU has been the topic of a number of analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. Wall Street Zen downgraded Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, December 13th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Kewaunee Scientific Stock Performance

The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.71 and a current ratio of 2.48. The company has a market cap of $112.88 million, a P/E ratio of 9.98 and a beta of 0.55. The stock’s fifty day moving average price is $38.45 and its two-hundred day moving average price is $45.50.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Wednesday, December 10th. The technology company reported $0.91 EPS for the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. The business had revenue of $70.10 million during the quarter. During the same quarter in the prior year, the firm earned $1.01 earnings per share.

Insider Activity at Kewaunee Scientific

In related news, CEO Thomas David Hull III sold 2,177 shares of the company’s stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $37.50, for a total transaction of $81,637.50. Following the completion of the sale, the chief executive officer directly owned 33,000 shares in the company, valued at $1,237,500. This represents a 6.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Over the last ninety days, insiders sold 4,719 shares of company stock worth $179,028. 13.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Minerva Advisors LLC lifted its holdings in shares of Kewaunee Scientific by 3.7% in the third quarter. Minerva Advisors LLC now owns 80,274 shares of the technology company’s stock worth $3,424,000 after acquiring an additional 2,832 shares during the last quarter. Punch & Associates Investment Management Inc. lifted its stake in Kewaunee Scientific by 61.9% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company’s stock valued at $2,989,000 after purchasing an additional 26,785 shares during the last quarter. American Century Companies Inc. boosted its position in Kewaunee Scientific by 12.5% in the second quarter. American Century Companies Inc. now owns 55,310 shares of the technology company’s stock valued at $3,247,000 after buying an additional 6,128 shares in the last quarter. De Lisle Partners LLP grew its stake in shares of Kewaunee Scientific by 6.7% during the second quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company’s stock worth $2,811,000 after buying an additional 3,029 shares during the last quarter. Finally, Royce & Associates LP bought a new stake in shares of Kewaunee Scientific during the third quarter worth $1,663,000. Institutional investors and hedge funds own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.